{"denoms":[{"counts":[{"groupId":"BG000","value":"46"}],"units":"Participants"}],"groups":[{"description":"Paclitaxel 175 mg/m2 IV over 3 hours followed by Carboplatin AUC = 6 IV over 30 minutes repeated every 21 days until disease progression or adverse effects prohibit further therapy","id":"BG000","title":"Paclitaxel Followed by Carboplatin"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"11.6","value":"65.5"}]}],"title":"Age at Study Entry"}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Customized","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"46"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}],"populationDescription":"Total eligible and treated participants"}